Chen Jenn-Tzong1 , Chang Kang-Wei1 , Farn Shiou-Shiow1 , Lin Wuu-Jyh2 ,*, Shiue Chyng-Yann3,
Lipophilicity is one of the significant mind radiopharmaceutical plan rules. Alzheimer's sickness PET imaging specialists dependent on lipophilicity change are [18F]RO6958948 [1] and[18F]Florbetapir, plan by supplanting with a Nitrogen component either in the fragrant ring of [18F]Flortaucipir or [18F]Florbetaben. The structure of [18F]FEONM (Figure 1) is intended to give higher lipophilicity than [18F]FDDNP. Structure alteration on a specific bioactive atom to expand its lipophilicity will be likewise potentially expanding the level of infiltrating blood cerebrum obstruction. Expanding the blood cerebrum obstruction crossing proportion, the particularity of this dynamic biomolecule focusing on impact may be diminished. Along these lines, we plan an ethyl oxide changed naphthol based Alzheimer infection positron outflow tomography imaging specialist [18F]FEONM, to think about the take-up impact of Tau tangle and Beta-amyloid. PET radiopharmaceuticals for mind imaging depend on extremely short half-life radionuclides, the vast majority of them will be rotted in one day. One of the longest half-life natural radionuclides is fluorine-18, in this way basic advance to creating PET radiopharmaceuticals online is radiofluorination response. The most elevated radiofluorination response yield can be produced using a carboxy glass reactor. In the carboxy glass reactor, the capacity of hole territory (FG) bend of radiofluorination yield can be drawn nearer with Gauss dispersion, Gauss, or Welch apodization work. After deciding the radiofluorination rate consistent, the length of the microfluidic plug stream reactor can be planned with an expository structure dependent on Welch apodization work. Mind hippocampus imaging relative explicit restricting proportion of [18F]FEONM on a Tau tangle P301S/PS19 transgenic mouse model is double cross higher than cerebellum, Beta amyloid Tg2576 transgenic mouse model is under two. On a triple transgenic 3xTg mouse model with both Tau tangle and Beta-amyloid framed, the take-up proportion of the hippocampus is 50% higher than the cerebellum. Consequently, [18F]FEONM is another Alzheimer PET imaging specialist. In addition, other than the transgenic mouse model, the streptozotocin actuated Tau tangle mouse model likewise shows higher cerebrum hippocampus [18F]FEONM take-up than the control mouse. From the transgenic mouse model imaging study, we discovered [18F]FEONM will takeup on both Tau tangle and Beta-amyloid transgenic mouse. In contrast with [18F]FDDNP, it shows no Beta-amyloid transgenic mice take-up in mind the hippocampus. This outcome speaks to a part of the particular authoritative of Tau tangle transgenic mouse of [18F]FDDNP has moved to Beta-amyloid. In this manner, Tau tangle and Beta-amyloid take-up status should be possible by [18F]FEONM at a similar time for conclusion Alzheimer illness. Radiation presentation will be half measurement contrasted with taking both imaging. These discoveries dependent on another plan presume that another PET radiopharmaceutical configuration has a similar idea like another radiofluorination microfluidic reactor plan. Either another synthetic structure or another numerical model contributes an accomplishment. For instance, an undeniable application is assessing helpful adjustment of sickness movement. At the finish of this survey, the creators incorporate outcomes from a pilot study exhibiting achievability of utilizing MRMI to identify restorative change of plaque movement in AD transgenic mice. Despite the species picked, transgenic advancements present hereditary changes. In this way, fruitful demonstrating requires the sickness to be related with a hereditary change or if nothing else for a theory to exist in regards to the presumable pathophysiology of the problem that can be displayed by a hereditary adjustment. To be helpful as a creature model, the transgenic living being must likewise have the option to show the fundamental obsessive, physiological, or conduct highlights of the human sickness. With quality focusing, rather than an unfamiliar transgene being presented, an endogenous quality in the mouse is adjusted. At first, the adjustment is made in particular cells named undeveloped stem (ES) cells. ES cell lines are gotten from beginning phase mouse undeveloped organisms and can be kept up uncertainly in an undifferentiated state in vitro yet hold the limit, when infused once more into a beginning phase mouse incipient organism, to blend in with the endogenous cells of the incipient organism and add to all tissues of the creating mouse, including the germline. The quality of interest is altered in ES cells by the presentation of a focusing on a vector that comprises an adjusted form of the endogenous quality. In ES cells, the focusing on vector recombines with the homologous endogenous quality and accordingly presents the hereditary adjustment. Quality focused on ES cells are then infused into This work is partly presented at joint Event on 12th International Conference on Genomics and Molecular Biology, April 15-17, 2019 Berlin, Germany Vol.9 No.4 Short Communication Advancements in Genetic Engineering 2020 wild sort blastocyst-stage mouse undeveloped organisms with the fanciful mice that outcome being combinations of the changed ES cells and wild sort blastocyst cells. The effective joining of the ES cells into the germline allows the hereditary alteration to be proliferated as a feature of the mouse genome, and this makes stable transgenic lines
Chen Jenn-Tzong1 , Chang Kang-Wei1 , Farn Shiou-Shiow1 , Lin Wuu-Jyh2 ,*, Shiue Chyng-Yann3,
Lipophilicity is one of the significant mind radiopharmaceutical plan rules. Alzheimer's sickness PET imaging specialists dependent on lipophilicity change are [18F]RO6958948 [1] and[18F]Florbetapir, plan by supplanting with a Nitrogen component either in the fragrant ring of [18F]Flortaucipir or [18F]Florbetaben. The structure of [18F]FEONM (Figure 1) is intended to give higher lipophilicity than [18F]FDDNP. Structure alteration on a specific bioactive atom to expand its lipophilicity will be likewise potentially expanding the level of infiltrating blood cerebrum obstruction. Expanding the blood cerebrum obstruction crossing proportion, the particularity of this dynamic biomolecule focusing on impact may be diminished. Along these lines, we plan an ethyl oxide changed naphthol based Alzheimer infection positron outflow tomography imaging specialist [18F]FEONM, to think about the take-up impact of Tau tangle and Beta-amyloid. PET radiopharmaceuticals for mind imaging depend on extremely short half-life radionuclides, the vast majority of them will be rotted in one day. One of the longest half-life natural radionuclides is fluorine-18, in this way basic advance to creating PET radiopharmaceuticals online is radiofluorination response. The most elevated radiofluorination response yield can be produced using a carboxy glass reactor. In the carboxy glass reactor, the capacity of hole territory (FG) bend of radiofluorination yield can be drawn nearer with Gauss dispersion, Gauss, or Welch apodization work. After deciding the radiofluorination rate consistent, the length of the microfluidic plug stream reactor can be planned with an expository structure dependent on Welch apodization work. Mind hippocampus imaging relative explicit restricting proportion of [18F]FEONM on a Tau tangle P301S/PS19 transgenic mouse model is double cross higher than cerebellum, Beta amyloid Tg2576 transgenic mouse model is under two. On a triple transgenic 3xTg mouse model with both Tau tangle and Beta-amyloid framed, the take-up proportion of the hippocampus is 50% higher than the cerebellum. Consequently, [18F]FEONM is another Alzheimer PET imaging specialist. In addition, other than the transgenic mouse model, the streptozotocin actuated Tau tangle mouse model likewise shows higher cerebrum hippocampus [18F]FEONM take-up than the control mouse. From the transgenic mouse model imaging study, we discovered [18F]FEONM will takeup on both Tau tangle and Beta-amyloid transgenic mouse. In contrast with [18F]FDDNP, it shows no Beta-amyloid transgenic mice take-up in mind the hippocampus. This outcome speaks to a part of the particular authoritative of Tau tangle transgenic mouse of [18F]FDDNP has moved to Beta-amyloid. In this manner, Tau tangle and Beta-amyloid take-up status should be possible by [18F]FEONM at a similar time for conclusion Alzheimer illness. Radiation presentation will be half measurement contrasted with taking both imaging. These discoveries dependent on another plan presume that another PET radiopharmaceutical configuration has a similar idea like another radiofluorination microfluidic reactor plan. Either another synthetic structure or another numerical model contributes an accomplishment. For instance, an undeniable application is assessing helpful adjustment of sickness movement. At the finish of this survey, the creators incorporate outcomes from a pilot study exhibiting achievability of utilizing MRMI to identify restorative change of plaque movement in AD transgenic mice. Despite the species picked, transgenic advancements present hereditary changes. In this way, fruitful demonstrating requires the sickness to be related with a hereditary change or if nothing else for a theory to exist in regards to the presumable pathophysiology of the problem that can be displayed by a hereditary adjustment. To be helpful as a creature model, the transgenic living being must likewise have the option to show the fundamental obsessive, physiological, or conduct highlights of the human sickness. With quality focusing, rather than an unfamiliar transgene being presented, an endogenous quality in the mouse is adjusted. At first, the adjustment is made in particular cells named undeveloped stem (ES) cells. ES cell lines are gotten from beginning phase mouse undeveloped organisms and can be kept up uncertainly in an undifferentiated state in vitro yet hold the limit, when infused once more into a beginning phase mouse incipient organism, to blend in with the endogenous cells of the incipient organism and add to all tissues of the creating mouse, including the germline. The quality of interest is altered in ES cells by the presentation of a focusing on a vector that comprises an adjusted form of the endogenous quality. In ES cells, the focusing on vector recombines with the homologous endogenous quality and accordingly presents the hereditary adjustment. Quality focused on ES cells are then infused into This work is partly presented at joint Event on 12th International Conference on Genomics and Molecular Biology, April 15-17, 2019 Berlin, Germany Vol.9 No.4 Short Communication Advancements in Genetic Engineering 2020 wild sort blastocyst-stage mouse undeveloped organisms with the fanciful mice that outcome being combinations of the changed ES cells and wild sort blastocyst cells. The effective joining of the ES cells into the germline allows the hereditary alteration to be proliferated as a feature of the mouse genome, and this makes stable transgenic lines
Abdulrahman Alshehri,
Rationale: The current therapeutic drugs such as, growth hormone (GH), granulocyte colony stimulating factor (GCSF) and leptin require once daily injections, which are inconvenient and expensive. Therefore, a number of approaches to reducing therapeutic regimens clearance have been tried mainly through conjugation with another moiety. One such technology already being employed is PEGylation; however this has been shown to be non-biodegradable and toxic. A previous study by Asterion has shown that the use of glycosylated linkers between two GH ligands to create protein tandems resulted in their glycosylation and an increased molecular weight (MW) whilst maintaining biological activity. The use of this technology using GCSF as an example will be presented, but can be easily applied to other molecules such as leptin. Hypothesis: The incorporation of variable glycosylated linkers between two GCSF ligands will create a construct with high molecular weight and protected from proteolysis resulting in reduced clearance without blocking bioactivity. Methodology: GCSF tandems with linkers containing between 2â?8 NAT glycosylation motifs and their respective controls (Q replaces N in the sequence motif NAT so there is no glycosylation) were cloned, and sequenced. Following expression in Chinese hamster ovary (CHO) cells, expressed protein was analysed by SDS PAGE to confirm molecular weights. In vitro bioactivity was tested using an AMLâ?193 proliferation assay. Immobilized metal affinity chromatography (IMAC) was used to purify the protein. Pharmacokinetic and pharmacodynamics properties of the purified GCSF tandem proteins were measured in normal Sprague Dawley rats with full ethical approval. Results: Purified glycosylated tandems show increased molecular weight above that of controls when analysed by SDS PAGE. All GCSF tandems show increased bioactivity in comparison to native GCSF. Following intravenous administration to rats, GCSF2NAT, GCSF4NAT, GCSF8NAT containing 2, 4 & 8 glycosylation sites respectively and GCSF8QAT (nonglycosylated GCSF tandem control) showed approximately 3â?fold longer circulating halfâ?life compared to that reported for the native GCSF (1.79 hours). Both GCSF2NAT and GCSF4NAT show a significant increase in the percentage of neutrophils over controls at 12 hours post injection. This effect however is short lived as the counts at 24+ hours are not significantly different to controls. GCSF8NAT shows an increase in the percentage of neutrophils that is only significant at 48 hours. Conclusion: Results show that the use of glycosylated linkers to generate GCSF tandems results in molecules with increased molecular weight, improved in vitro bioactivity, longer circulating halfâ?lives and enhanced neutrophil population when compared to both native GCSF and the nonâ?glycosylated tandem protein
Yana Bai1 , Junjun Huang1,2, Zhiyuan Cheng2 , Desheng Zhang3 , Juansheng Li2 , Jiao Ding3 , Xiaobing Hu2 , Haiyan Li3 , Xiping Shen2 , Xiaoywei Ren2 , Tongzhang Zheng4 and Ning Cheng2 *
Objectives: To reveal the relationship between gallstone and metabolic syndrome, in order to provide evidence for prevention and treatment of gallstones and metabolic syndrome Jinchang cohort. Methods: The baseline eventually included 20,969 people and a total of 11,872 people completed the follow-up. The study was used to analyse the relationship between metabolic syndrome and the risk of gallstones, and was also used to analyse the effects of gallstones on the development of metabolic syndrome, and calculate the risk ratio and its 95% confidence interval (HR, 95%CI), based on Jinchang cohort. Results: The prevalence of metabolic syndrome was 34.8%, 36% and 33.2% in the total population, men and women. Multivariate Cox regression analysis showed that age, drinking, BMI and family history of hypertension are risk factors of cholecystitis and high education level, frequently exercise were protective factors of cholecystitis. The prevalence of gallstones in the Jinchang cohort was 13.01% overall, 16.64% in females, 10.73% in males. After adjusting for age, smoking, drinking et al, the prevalence risk (OR, 95%CI) of gallstones in men, women and the general population with metabolic syndrome was respectively 1.57 (1.33-1.85), 1.87 (1.55-2.26) and 1.58 (1.40-1.78) for those without metabolic syndrome. The incidence of gallstones in the general population with metabolic syndrome was 4.1%, and the incidence of gallstones in the population without metabolic syndrome was 2% in the Jinchang cohort. After adjusting for age, smoking, drinking et al, the risk of gallstones in the total population and female population with metabolic syndrome was higher than that of those without metabolic syndrome, with HR (95%CI) of 1.291 (1.016-1.642) and 1.466 (1.094-1.964). Along with the increase in number of abnormal metabolic syndrome components, the incidence of gallstones also gradually rise, when there are five abnormal metabolic components, the incidence of gallstones of total population reached 10.9%, the women reached 12.5%. The risk of gallstones in women and total population with the five abnormal metabolic components are respectively 7.922 times and 5.011 times that of normal population. Cholecystectomy was found to be significantly associated with incident type 2 diabetes mellitus among individuals with prediabetes (HR = 1.703; 95% CI, 1.299–2.233). Conclusions: Metabolic syndrome can increase the risk of gallstones in the general population and women, and with the increase of abnormal number of components of metabolic syndrome, the risk of gallstones increases gradually
C Furne1 , G Clermont1 , Meh Begnier1 , A Letessier1 , C Correia2 , R A Sousa2 and R L Reis2,3,4
Introduction: Limited regeneration occurs spontaneously following spinal cord injury (SCI). Biomaterials hold great promising for the regeneration of many tissues including the spinal cord (SC). The neurograft collaborative consortium proposed a novel micro-porous collagen conduit to restore SC functions. The conduit was designed to create a bridge across the lesion and provide trophic support to the survival of neurons and axons outgrowth. The conduit was tested in a new paraplegic rat model that mimicked irreversible acquired paraplegia and in a rat transaction model. Methods: Paraplegia was induced in a rat model by a contusion at thoracic vertebra T9. Four weeks after contusion the injured portion of the SC was removed and replaced by the conduit (conduit), transected without implantation (transection control), or left untreated (contusion control). The motor functions were evaluated for 8 weeks after implantation using the Basso, Beattie, and Bresnahan (BBB) rating scale. The inflammation and regeneration of the SC with/without conduits were investigated using histopathologic evaluation. The conduit was also combined with mesenchymal stem cells (MSC) and tested in a single transaction model. The transaction was performed at T9 and the SC was implanted with the conduit (conduit), the conduit combined with neural/glial-differentiated MSC (conduit+MSC) or left empty (control transection). SCI regeneration was evaluated similarly over 12 weeks. The conduit was tested for its biocompatibility following ISO 10993 standard for irritation, cytotoxicity, acute systemic toxicity, degradation kinetics, and genotoxicity. Results: The conduit demonstrated its biocompatibility in all testing performed according to ISO 10993 standards. Its degradation kinetic was compatible with in vitro culture of MSC, allowing conduit functionalization before in vivo implantation. Its degradation kinetic was also compatible with the SC regeneration process, given that, after the treatment period, the conduit was adherent to the surrounding spinal cord and restored the physical continuity of the spinal cord. Independent of the paraplegia model tested, BBB evaluation demonstrated no significant improvement of motor functions following implantation of the conduit, with or without MSC. The histopathologic evaluation is under process. Discussion & Conclusion: To achieve cellular regeneration and functional recovery upon SCI has been a demanding challenge leading to the development of highly complex therapeutic systems including a biomaterial device with specific characteristics and bioactive agents (cells/ molecules). Such systems should ensure suitable mechanical properties, cell-adhesion, electrical activity, and biodegradability. While these parameters have been seized within neurograft development, no motor function was restored after transection+conduit implantation; demonstrated by the BBB rating evaluation. Independent of the in vivo model used, outcomes were equivalent. Regeneration of the spinal cord is still being investigated by extensive histopathologic analysis for further understanding of the on-going repair mechanisms and future fine-tuning of the therapeutic system. Nevertheless, the neurograft conduit has demonstrated its biocompatibility, becoming valuable as a scaffold to test other combinations of active molecules and/or stem cells.
Laith N. Al-Eitan1,2*, Amneh H. Tarkhan1 , Mansour A. Alghamdi3 , Firas A. Al-Qarqaz4,5 , Hadeel S. AlKofahi4,
Known to be the reason for moles in people, the human papillomaviruses (HPV) are an irresistible gathering of DNA infections that are communicated between people by means of skin-to-skin contact. Because of the way that moles are found in 7 to 12% of the populace, HPV contamination is a generally normal illness that affects around 1 of every 10 individuals through their lifetime. Upon broad audit of overall writing, it was discovered that no papers explored the quality articulation profiles of HPV-prompted moles. The principle point of this investigation is to decide if there is a distinction in the quality articulation profiles of moles and sound skin in HPV+ people. RNA-sequencing innovation was used without precedent for Jordan to decide if there is a distinction in quality articulation between HPV-initiated moles and sound skin. Correlations between HPV-incited moles and solid skin from Jordanian Arab patients were completed utilizing the Illumina HiSeq 2500 sequencing framework. Different bioinformatics programming were used for measurement of differential articulation, quality set enhancement investigation, pathway examination, and heat map bunching. HPV-actuated moles were found to have a profoundly huge and exceptional hereditary mark. A significant number of the up-directed qualities were identified with malignancy and infection (WIF1, HMGCS2, CLU, and PTGIS), while a few down-controlled qualities were related with quality hindrance (SPINK6, PI3, SERPINB4, SERPINB3). Also, the best 500 differentially communicated qualities were discovered to be related with insusceptible and immune system pathways, for example, the neutrophil degranulation, cost like receptor 7/8 (TLR 7/8) course, cost like receptor 9 (TLR9) course, and cost like receptor 10 (TLR10) pathways, among others. HPV-prompted moles have an unmistakable quality articulation design that separates them from sound skin yet shares a lot of practically speaking with different sicknesses of the skin. Future lines of examination must explore the qualities of interest revealed in this investigation in an individual way to find out the degree of their pathogenicity. The human papillomavirus (HPV) is a DNA infection that has been related with numerous sicknesses and is the complete reason for basically all cervical malignancy cases. Almost 200 sorts of HPV have been described, and these sorts are named high-danger or generally safe relying upon their capability to cause destructive or generous injuries, individually. 4.5% of new disease cases overall are brought about by high-hazard HPV contamination, however generally safe sorts regularly show as moles. Basic moles (Verruca vulgaris) are by a wide margin the most common sort of mole, making up 70% of all non-genital cutaneous moles, and are believed to be amiable in nature. Human skin is made out of two layers, the epidermis and the dermis, and HPV only focuses on the lowermost epidermal layer, the layer basale, to set up a tenacious disease, after which it captures the keratinocyte separation measure with the end goal of the beneficial viral life cycle. Correspondingly, HPV science varies in basal and suprabasal keratinocytes, the last of which are associated with various phases of epithelial separation. Keratinocytes make up 90% of every single epidermal cell, and bothers to their separation make the skin more helpless to contamination and illness. Presently, there is no remedy for HPV itself, and its treatment centers around the lightening of clinical indications until the disease is normally cleared by the insusceptible framework. Nonetheless, there is no convincing proof concerning whether the infection is totally dispensed with from the body or essentially brought down to imperceptible levels. While much examination has been committed to the hereditary qualities of HPV-related malignancies, there is a deficiency of data concerning the hereditary foundation of non-genital cutaneous moles, which shows a squeezing need to more readily comprehend their etiology. Consequently, the point of the current examination is to give a genome-wide correlation of the transcriptomes of basic moles and ordinary skin utilizing cutting edge sequencing. The current investigation served to explain the hereditary foundation of HPV contamination with regards to non-genital cutaneous moles. The discoveries of the current examination featured dysregulation of various qualities which may assume a basic part in mole development, including KRT16, EPGN, C15orf59, CYB561A3, and FCGRT. Insusceptible framework related pathways were discovered to be related with distinguished DE qualities including neutrophil degranulation, myeloid separation factor 88, and cost like receptors. Our information likewise proposes that few qualities engaged with the invulnerable reaction may assume a basic function in encouraging the HPV contamination measure. In fact, invulnerable cell signature investigation demonstrated distinctive movement levels of numerous cells associated with the resistant framework including NKT, DC, and Treg cells. A considerable lot of the qualities discovered to be involved in like manner moles were not the subject of past friend evaluated examination, recommending future headings and lines of exploration focusing on those individual qualities just as the articulation examples of individual HPV types.
Hyoung Doo Shin*, Yeon Su Kim, In Ki Baek and Hyun Sub Cheong
DOI: 10.37421/2684-6039.2023.7.141
Fasting blood glucose (FBG) level is prevalent trait to predict several diseases. In the present study, We identified markers for prediction of blood glucose level. The genotype data of a total of 5,013 samples (2,373 men and 2,640 women) were obtained from the Korea Association Resource (KARE) project. We collected markers from a genome-wide association study (GWAS) catalog which included additional markers from nearby regions of GWAS catalog markers. In order to establish a FBG prediction model, we selected significant single nucleotide polymorphisms (SNPs) using a 10-fold cross-validation. In addition, we validated our prediction model using the final validation set. We selected a total of 7 SNP comprised of 2 SNPs (rs7754840 and rs12699673) for the men and 5 SNPs (rs102275, rs1574285, rs2908289, rs6494307 and rs917793) for the women from the 10-fold cross-validation process. The results of the 10-fold across-validation process in the men and the women indicated upward trends of FBG levels. Also, we validated our prediction model using the final validation set. In the final validation set, increased trends were observed across all of the sets. Our prediction model for FBG may be helpful to further FBG related studies.
DOI: 10.37421/2684-6039.2023.7.142
Trial formulations are frequently found to be nonspecific, ineffective, thermally or hydrolytically unstable, or toxic, making it extremely difficult to engineer vaccine-based therapeutics for infectious diseases. The therapeutic landscape for treating infectious diseases has greatly improved thanks to vaccines, as has the threat posed by therapeutic and preventative measures. In addition, despite making production processes more cumbersome, the development of recombinant technologies has greatly facilitated vaccine development by mitigating risks like virulence reversion. Recombinant technology can also improve seroconversion through kinetic and nonkinetic strategies that are discussed in this paper. DNA-based vaccines and amino acid-based vaccines have both seen significant advancements thanks to recombinant technologies.
DOI: 10.37421/2684-6039.2023.7.143
The eyes, kidneys and cardiovascular system are among the tissues and organs affected by diabetes, a chronic metabolic disorder. The prevalence of diabetes in the world is 8.8 percent, with approximately 90 percent of cases being type 2 diabetes, according to the World Health Organization. In the early stages of diabetes, there are no significant clinical signs or symptoms. As a result, screening can be a useful tool for reducing diabetic complications. The Middle East's health care system has been burdened with exorbitant costs as a result of the alarming rise in diabetes prevalence over the past few decades. We investigated the role of single-nucleotide polymorphisms (SNPs) in the pathogenesis of diabetes in the Middle Eastern population because genetic changes are one of the major risk factors associated with diabetes predisposition. We evaluated the Middle Eastern population's molecular pathology of diabetes in this review, paving the way for the introduction of an effective SNP-based diagnostic panel for diabetes screening. Since there are 370 million people living in the Middle East; The current review may serve as a useful model for the implementation of SNP-based diagnostic panels in additional populations and nations.
DOI: 10.37421/2684-6039.2023.7.144
DOI: 10.37421/2684-6039.2023.7.145
DOI: 10.37421/2684-6039.2024.8.181
The replication of chromosomal DNA in humans is a fundamental process essential for cellular proliferation and inheritance of genetic information. Initiation marks the beginning of this intricate process, orchestrating the assembly of replication machinery at specific sites on the DNA molecule. This article delves into the mechanisms underlying initiation processes during DNA replication in humans, exploring key proteins, regulatory factors, and the coordination required for faithful duplication of the genome.
DOI: 10.37421/2684-6039.2024.8.188
Skin T-Cell Lymphoma (STCL), a rare form of non-Hodgkin lymphoma, presents a complex challenge in oncology due to its heterogeneity and resistance to conventional treatments. However, recent advancements in genomic research have shed light on promising genetic markers that could revolutionize the management of STCL. This article delves into the significance of these genetic markers in STCL treatment, exploring their implications for personalized medicine and the future of oncology.
DOI: 10.37421/2684-6039.2024.8.187
In the ongoing battle against infectious diseases, vaccines stand as one of the most powerful tools humanity has devised. Traditional vaccines, while effective, often require multiple doses and intricate manufacturing processes. However, a breakthrough in vaccine technology has emerged in the form of single-dose immunogenic DNA vaccines coding for live-attenuated Alpha viruses. This innovative approach offers significant advantages over conventional vaccines, potentially revolutionizing the field of vaccination.
DOI: 10.37421/2684-6039.2024.8.185
DOI: 10.37421/2684-6039.2024.8.189
Somatic BRCA mutations, occurring in non-germline cells, have garnered significant attention due to their predictive value and therapeutic implications, particularly in the context of cancer management. The discovery of BRCA mutations, initially linked with hereditary breast and ovarian cancers, has now extended to various other cancers, including prostate, pancreatic, and others. Understanding the predictive value of somatic BRCA mutations and their therapeutic significance is crucial for personalized cancer treatment strategies. This article aims to delve into the predictive implications of somatic BRCA mutations and explore the therapeutic avenues they offer in cancer management.
DOI: 10.37421/2684-6039.2024.8.186
DOI: 10.37421/2684-6039.2024.8.182
DOI: 10.37421/2684-6039.2024.8.184
DOI: 10.37421/2684-6039.2024.8.190
DOI: 10.37421/2684-6039.2024.8.183
DOI: 10.37421/2684-6039.2024.8.191
DOI: 10.37421/2684-6039.2024.8.192
DOI: 10.37421/2684-6039.2024.8.193
DOI: 10.37421/2684-6039.2024.8.194
DOI: 10.37421/2684-6039.2024.8.195
Genetic diversity and population structure are fundamental aspects of evolutionary biology, with implications for understanding human health, biodiversity conservation and agricultural sustainability. Next-generation sequencing (NGS) technologies have revolutionized our ability to explore genetic variation within and between populations at unprecedented resolution. In this mini-review, we highlight recent advances in the application of NGS techniques for elucidating genetic diversity and population structure across diverse taxa. We discuss the utility of whole-genome sequencing, genotyping-by-sequencing and related methodologies for characterizing genetic variation, detecting population differentiation and inferring demographic history. Furthermore, we explore the challenges and opportunities associated with NGS-based approaches for studying genetic diversity and population structure and discuss future directions in the field.
DOI: 10.37421/2684-6039.2024.8.196
Genomic instability is a hallmark of cancer, driving tumorigenesis and tumor evolution. Understanding the mechanisms underlying genomic instability is crucial for developing effective cancer therapies. This mini-review explores the various causes of genomic instability, including DNA damage, replication errors and impaired DNA repair mechanisms. We discuss the implications of genomic instability for cancer development, progression and therapeutic resistance. Furthermore, we highlight emerging therapeutic strategies targeting genomic instability pathways for cancer treatment.
DOI: 10.37421/2684-6039.2024.8.197
Genomic investigation of the evolutionary dynamics of genomic variation across species sheds light on the mechanisms driving biodiversity and adaptation. Comparative genomics, enabled by advances in sequencing technologies and computational tools, has revolutionized our understanding of genome evolution, uncovering conserved genomic elements, lineage-specific innovations and evolutionary forces shaping genetic diversity. In this mini-review, we explore key concepts and methodologies in comparative genomics, highlight recent insights into the evolutionary dynamics of genomic variation and discuss the implications for understanding species divergence, adaptation and speciation.
DOI: 10.37421/2684-6039.2024.8.198
The impact of genetic variation on drug response is a critical aspect of personalized medicine, aiming to optimize therapeutic outcomes by tailoring treatment regimens to individual genetic profiles. Genetic variability in drug-metabolizing enzymes, drug transporters and drug targets can significantly influence pharmacokinetics and pharmacodynamics, leading to inter-individual variability in drug efficacy, toxicity and adverse reactions. This mini-review provides an overview of the role of genetic variation in drug response and its implications for personalized medicine. We discuss key genetic determinants of drug response, approaches for pharmacogenomic testing, challenges in implementation and future perspectives for integrating genetic information into clinical practice.
DOI: 10.37421/2684-6039.2024.8.199
DOI: 10.37421/2684-6039.2024.8.200
Journal of Genetics and DNA Research received 3 citations as per Google Scholar report